David Sumerauer Selected Research

David Sumerauer Research Topics

15	Neoplasms (Cancer) 01/2022 - 07/2005
5	Medulloblastoma 01/2021 - 07/2014
3	Glioma (Gliomas) 01/2021 - 01/2020
3	Synovial Sarcoma (Synovioma) 08/2009 - 09/2007
2	Rhabdoid Tumor (Rhabdoid Tumors) 12/2021 - 09/2014
2	Diffuse Intrinsic Pontine Glioma 10/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2014
1	Typical Teratoid Rhabdoid Tumor 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Brain Neoplasms (Brain Tumor) 11/2021
1	Second Primary Neoplasms (Neoplasms, Second) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Necrosis 07/2020
1	Astrocytoma (Pilocytic Astrocytoma) 01/2020
1	Ototoxicity 01/2020
1	Ependymoma 01/2020
1	Genomic Instability 12/2019
1	Disease Progression 10/2019
1	Turcot syndrome 01/2019
1	Circulating Neoplastic Cells 01/2018
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 03/2016
1	Pancytopenia 03/2016
1	Polyneuropathies (Polyneuropathy) 03/2016
1	Sepsis (Septicemia) 03/2016
1	Pathologic Complete Response 09/2014
1	Sarcoma (Soft Tissue Sarcoma) 08/2009
1	Breast Neoplasms (Breast Cancer) 12/2007
1	Peripheral Primitive Neuroectodermal Tumors (Peripheral Neuroectodermal Tumor) 11/2002

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
2	Biological ProductsIBA 12/2021 - 09/2017
2	NucleotidesIBA 01/2020 - 12/2019
2	dipinacoline glutamateIBA 10/2019 - 01/2017
1	Tuberculin (PPD)IBA 01/2022
1	Decitabine FDA Link 12/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Arginine (L-Arginine)FDA Link 12/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2020
1	Valine (L-Valine)FDA Link 12/2020
1	Histones (Histone)IBA 12/2020
1	Bevacizumab (Avastin)FDA Link 07/2020
1	N 30IBA 01/2020
1	plerixafor FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 03/2016
1	ChromatinIBA 03/2016
1	Vincristine (Oncovin)FDA LinkGeneric 03/2016
1	Sucrose (Saccharose)IBA 09/2014
1	SMARCB1 ProteinIBA 09/2014
1	oblimersen (G3139)IBA 08/2009
1	Cyclin D1IBA 08/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2007
1	Messenger RNA (mRNA)IBA 12/2007
1	SYT-SSX fusion proteinIBA 09/2007
1	Indicators and Reagents (Reagents)IBA 07/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2002

8	Therapeutics 12/2021 - 08/2007
3	Radiotherapy 01/2021 - 01/2020
3	Drug Therapy (Chemotherapy) 01/2020 - 07/2014
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Cranial Irradiation 01/2021
1	Re-Irradiation 07/2020
1	Hematopoietic Stem Cell Mobilization 01/2020
1	Chemoradiotherapy 01/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2018